Florence Healthcare raises $7.1m to build out ‘sponsor portal’

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/CarlosAndreSantos)
(Image: Getty/CarlosAndreSantos)

Related tags: Florence Healthcare, Clinical trials software

The clinical trials software company has raised $7.1m to connect its network of more than 5,000 clinical trial sites with sponsors and CROs via the ‘Florence eHub.’

Based in Atlanta, GA-based, Florence Healthcare has raised $7.1m in a Series B financing round led by Fulcrum Equity Partners with participation from Atrium Health and Bee Partners.

Over the last five years, the company has built a network of more than 5,000 clinical trial sites that are managing studies on its platform.

The funds will be used to support the company as it works to connect these sites with contract research organizations (CROs) and sponsors to enable study document and data exchange.

Sponsors and CROs are needing the ability to exchange documents in real-time with research sites [and] we don’t believe site portals are the answer to collecting documents from sites,”​ said Blake Adams, head of marketing at Florence.

Instead, the company ‘flips the script’ and has developed a central platform for sites – a ‘sponsor portal’ that provides sponsors with integrated access through the ‘Florence eHub.’

“What differentiates us from some others out there, is that we are a site-centric organization,” ​added Adams. “Our platforms are designed for the enterprise research site. Each research site can set up the platform in a way that matches their workflows and needs, and then they are able to standardize that across their organization.”

For sponsors, Adams said this typically drives down start-up time by 43-44%. The platform also enables remote monitoring, with around 48% of its usage on a monthly basis being monitors and CRAs logging in to remotely monitor and access those research sites, he explained.

Additionally, Adams stressed Florence’s focus on the customer experience – the ‘post-purchase point’ and what the company calls its ‘white-glove service.’

“We help sites build out SOPs, training and workflows, and really hold their hand through anywhere from three months to eight months because we believe technology is change management play,”​ said Adams. “Just handing the keys to software doesn’t work – It really requires that organizational change management strategy.”

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more